{"id":55942,"date":"2023-04-18T14:04:18","date_gmt":"2023-04-18T12:04:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/"},"modified":"2023-04-18T14:04:18","modified_gmt":"2023-04-18T12:04:18","slug":"rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/","title":{"rendered":"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<i>Part of RapidAI\u2019s industry-leading stroke solution, Rapid NCCT Stroke supports faster treatment and transfer decisions while driving greater equity of care<\/i><\/p>\n<p>SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.rapidai.com%2F&amp;esheet=53382701&amp;newsitemid=20230418005344&amp;lan=en-US&amp;anchor=RapidAI&amp;index=1&amp;md5=15f857f3391b43cbc60504bb3654e393\" rel=\"nofollow noopener\" shape=\"rect\">RapidAI<\/a>, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid NCCT Stroke \u2013 a major addition to the RapidAI suite of non-contrast based solutions for stroke and trauma care, and the<b> first and only FDA cleared medical device<\/b> to detect suspected intracranial hemorrhage (ICH) and large vessel occlusion (LVO) from value-based CT imaging.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/4\/rapid-AI-logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg\"><\/a><\/p>\n<p>\nRapid NCCT Stroke uses artificial intelligence to analyze non-contrast CT (NCCT) images to determine suspicion of ICH and LVO of the distal internal carotid artery (ICA) and middle cerebral artery (MCA-M1). The fully automated system then delivers triage and prioritization notifications through PACS, email, and the Rapid mobile app. Because NCCT imaging is readily available and is the initial imaging modality used for stroke and trauma patients, care teams can make time-sensitive workflow and transfer decisions faster. For hospitals that do advanced imaging, Rapid NCCT Stroke may significantly reduce the time between CT and CTA scans.<\/p>\n<p>\nRapid NCCT Stroke supports teams in:<\/p>\n<ul class=\"bwlistdisc\">\n<li>\nAccelerating door-to-imaging and door-to-decision time<\/li>\n<li>\nMaking faster transfer decisions<\/li>\n<li>\nImproving equity of care by giving centers of all levels greater access to advanced value-based CT imaging technology that may improve decision making and impact patient outcomes<\/li>\n<\/ul>\n<p>\n\u201cThis technology will not only have an enormous impact on stroke care here in the U.S. but also globally, by giving care teams at small, local, or regional facilities around the world access to advanced clinical decision support technology too often only available at comprehensive stroke centers,&#8221; said Karim Karti, CEO of RapidAI. \u201cOur hope is that by providing better information early for more informed treatment and transfer decisions, Rapid NCCT Stroke will support faster stroke care and better patient outcomes. This is an incredible achievement for the team and yet another example of RapidAI\u2019s continued leadership in creating the next evolution of stroke care technology.\u201d<\/p>\n<p>\nTo learn more about how RapidAI is transforming stroke care, please visit: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.rapidai.com%2Fstroke&amp;esheet=53382701&amp;newsitemid=20230418005344&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.rapidai.com%2Fstroke&amp;index=2&amp;md5=bbfd04fa35c5d5f8ed6922539d042638\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.rapidai.com\/stroke<\/a><\/p>\n<p>\n<b>About RapidAI<\/b><\/p>\n<p>\n<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.rapidai.com&amp;esheet=53382701&amp;newsitemid=20230418005344&amp;lan=en-US&amp;anchor=RapidAI&amp;index=3&amp;md5=daf443ca9ab70bbf0d22a570dcc6aea7\" rel=\"nofollow noopener\" shape=\"rect\">RapidAI<\/a> is the global leader in using AI to combat life-threatening vascular and neurovascular conditions. Leading the next evolution of clinical decision-making and patient workflow, RapidAI is empowering physicians to make faster decisions for better patient outcomes. Based on intelligence gained from nearly 10 million scans in more than 2,000 hospitals in over 100 countries, the Rapid\u00ae platform transforms care coordination, offering care teams a level of patient visibility never before possible. RapidAI \u2013 where AI meets patient care.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nErin (Dixon) Erban<br \/>\n<br \/>Merritt Group<br \/>\n<br \/>774.573.3941<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;:&#x72;a&#112;&#x69;&#100;&#x61;&#105;&#x40;m&#x65;r&#114;&#x69;&#116;&#x74;&#103;&#x72;&#112;&#x2e;c&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#114;&#x61;&#x70;&#105;&#x64;&#x61;i&#x40;&#x6d;e&#114;&#x72;i&#116;&#x74;g&#114;&#x70;&#46;&#99;&#x6f;m<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Part of RapidAI\u2019s industry-leading stroke solution, Rapid NCCT Stroke supports faster treatment and transfer decisions while driving greater equity of care SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid NCCT Stroke \u2013 a major addition &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55942","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Part of RapidAI\u2019s industry-leading stroke solution, Rapid NCCT Stroke supports faster treatment and transfer decisions while driving greater equity of care SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid NCCT Stroke \u2013 a major addition ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-18T12:04:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage\",\"datePublished\":\"2023-04-18T12:04:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/\"},\"wordCount\":462,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230418005344\\\/en\\\/1765916\\\/21\\\/rapid-AI-logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/\",\"name\":\"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230418005344\\\/en\\\/1765916\\\/21\\\/rapid-AI-logo.jpg\",\"datePublished\":\"2023-04-18T12:04:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230418005344\\\/en\\\/1765916\\\/21\\\/rapid-AI-logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230418005344\\\/en\\\/1765916\\\/21\\\/rapid-AI-logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/","og_locale":"en_US","og_type":"article","og_title":"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage - Pharma Trend","og_description":"Part of RapidAI\u2019s industry-leading stroke solution, Rapid NCCT Stroke supports faster treatment and transfer decisions while driving greater equity of care SAN MATEO, Calif.&#8211;(BUSINESS WIRE)&#8211;RapidAI, the global leader in neurovascular and vascular AI-enhanced clinical decision support and patient workflow, today announced it has received FDA 510(k) clearance for Rapid NCCT Stroke \u2013 a major addition ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-18T12:04:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage","datePublished":"2023-04-18T12:04:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/"},"wordCount":462,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/","url":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/","name":"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg","datePublished":"2023-04-18T12:04:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230418005344\/en\/1765916\/21\/rapid-AI-logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rapidai-receives-first-and-only-fda-510k-clearance-of-non-contrast-ct-imaging-product-to-accelerate-acute-stroke-triage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RapidAI Receives First and Only FDA 510(k) Clearance of Non-Contrast CT Imaging Product to Accelerate Acute Stroke Triage"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55942","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55942"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55942\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55942"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55942"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55942"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}